Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 8/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | CCNC | P24863 | 1/20 | 0.54 |
| ▸ | CDK8 | P49336 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29655599 | 1.00 | KMT2A (0.58) | KMT2AALOX15CCNCCDK8ALDH1A1 | |
| Water SCHEMBL28745933 | 0.98 | KMT2A (0.57) | KMT2AALOX15CCNCCDK8ALDH1A1 | |
| Hydrochloric Acid SCHEMBL27556246 | 0.98 | KMT2A (0.57) | KMT2AALOX15CCNCCDK8ALDH1A1 | |
| Hydrochloric Acid SCHEMBL709385 | 0.98 | KMT2A (0.57) | KMT2AALOX15CCNCCDK8ALDH1A1 | |
| SCHEMBL31123876 | 0.86 | KMT2A (0.56) | KMT2AALOX15CCNCCDK8ALDH1A1 | |
| SCHEMBL876393 | 0.86 | KMT2A (0.56) | KMT2AALOX15CCNCCDK8ALDH1A1 | |
| SCHEMBL13113097 | 0.85 | KMT2A (0.55) | KMT2AALOX15CCNCCDK8ALDH1A1 | |
| SCHEMBL6294601 | 0.83 | KMT2A (0.57) | KMT2AALOX15CCNCCDK8ALDH1A1 | |
| SCHEMBL9163020 | 0.83 | KMT2A (0.53) | KMT2AALOX15CCNCCDK8ALDH1A1 | |
| SCHEMBL2625463 | 0.83 | KMT2A (0.54) | KMT2AALOX15CCNCCDK8ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 563 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025243208-A2 | PROCESS FOR THE PREPARATION AND/OR PURIFICATION OF POLYETHYLENE GLYCOL AND ITS DERIVATIVES, OBTAINED PRODUCT AND USES THEREOF | HOVIONE - FARMACIÊNCIA, SA (PT) | 2025-11-27 | — | — | WO | claimed |
| CN-113396332-B | Method for evaluating pregnancy progression and premature abortion for clinical intervention and use thereof | 斯坦福大学托管董事会 | 2025-02-11 | — | — | CN | claimed |
| US-20240358719-A1 | Formulations for Prolonging Gestation and for Complications of Menstruation or Gestation | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-10-31 | — | — | US | claimed |
| EP-4313061-A1 | FORMULATIONS FOR PROLONGING GESTATION AND FOR COMPLICATIONS OF MENSTRUATION OR GESTATION | The Board of Trustees of the Leland Stanford Junior University (US) | 2024-02-07 | — | — | EP | claimed |
| CN-115304542-B | Synthesis process of 3-hydroxypyridine | 湖南华纳大药厂手性药物有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-117202910-A | Formulations for prolonging pregnancy and for menstruation or pregnancy complications | 斯坦福大学托管董事会 | 2023-12-08 | — | — | CN | claimed |
| US-20230298758-A1 | Systems and Methods for Evaluating Gestational Progress and Applications Thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2023-09-21 | — | — | US | claimed |
| EP-4241285-A1 | SYSTEMS AND METHODS FOR EVALUATING GESTATIONAL PROGRESS AND APPLICATIONS THEREOF | The Board of Trustees of the Leland Stanford Junior University (US) | 2023-09-13 | — | — | EP | claimed |
| CN-115304542-A | Synthesis process of 3-hydroxypyridine | 湖南华纳大药厂手性药物有限公司 | 2022-11-08 | — | — | CN | claimed |
| US-20220339176-A1 | Methods of Treatments to Prolong Gestation and Complications of Menstruation or Gestation | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2022-10-27 | — | — | US | claimed |
| CN-1295228-C | Nitryl methylene derivatives and uses thereof | UNIV EAST CHINA SCIENCE & TECH (CN) | 2007-01-17 | — | — | CN | claimed |
| WO-2006051553-A1 | PROCESS FOR PREPARING A PURE POLYMORPHIC FORM OF 3-PYRIDYL-1-HYDROXYETHYLIDINE-1,1-BISPHOSPHONIC ACID SODIUM SALT | JUBILANT ORGANOSYS LIMITED (IN) | 2006-05-18 | — | — | WO | claimed |
| CN-1665825-A | Use of certain diluents for making bisphosphonic acids | TEVA PHARMA (IL) | 2005-09-07 | — | — | CN | claimed |
| CN-1211392-C | Preparation process of N-amino-1-hydroxyalkylene-1,1-diphosphonic acid | MERCK & CO INC (US) | 2005-07-20 | — | — | CN | claimed |
| CN-1308082-A | Preparation process of N-amino-1-hydroxyalkylene-1,1-diphosphonic acid | MERCK & CO INC (US) | 2001-08-15 | — | — | CN | claimed |
| US-5939568-A | Accelerated catalysis of olefinic epoxidations | THE SCRIPPS RESEARCH INSTITUTE (US) | 1999-08-17 | — | — | US | claimed |
| WO-1998033786-A9 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | — | 1998-12-30 | — | — | WO | claimed |
| WO-1998033786-A1 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-08-06 | — | — | WO | claimed |
| CN-1134703-A | Process for the preparation of N-amino-1-hydroxyalkylene-1, 1-diphosphonic acids | MERCK & CO INC (US) | 1996-10-30 | — | — | CN | claimed |
| CN-1035287-A | The neighbour of weeding-methoxycarbonyl sulfonylurea | DU PONT (US) | 1989-09-06 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220339176-A1 | Methods of Treatments to Prolong Gestation and Complications of Menstruation or Gestation | PGF, GNRHR, PTGDR | KMT2A 2199/4885ALOX15 1951/4885CCNC 38/4885 |
| US-20240358719-A1 | Formulations for Prolonging Gestation and for Complications of Menstruation or Gestation | PGF, GNRHR, PTGDR | KMT2A 2264/4885ALOX15 1827/4885CCNC 27/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.